national patent development_corp. said_0 it plans to purchase as many as 200,000 common_shares of its 81%-controlled interferon sciences inc. unit in periodic , open-market purchases . the 200,000 shares are about 23_% of interferon 's common_shares outstanding , excluding national patent 's stake . noting the recent food and drug_administration approval of interferon 's genital warts treatment , national patent said_0 it believes_0 interferon 's stock is undervalued .